Metabolism of 7-benzyloxy-4-trifluoromethylcoumarin by human hepatic cytochrome P450 isoforms

Xenobiotica

Volumn 30, Issue 10, 2000, Pages 955-969

  Renwick, A B ^a   Surry, D ^b   Price, R J ^a   Lake, B G ^a   Evans, D C ^c  

^a TNO BIBRA International Ltd   (United Kingdom)

^b NEUROSCIENCE RESEARCH CENTRE   (United Kingdom)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 BENZYLOXY 4 TRIFLUOROMETHYLCOUMARIN; ANTIBODY; COUMARIN DERIVATIVE; CYTOCHROME P450; CYTOCHROME P450 2C19; CYTOCHROME P450 3A; CYTOCHROME P450 3A4; DIETHYLDITHIOCARBAMIC ACID; MEPHENYTOIN; QUINIDINE; SULFAPHENAZOLE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG METABOLISM; ENZYME INHIBITION; ENZYME KINETICS; HUMAN; HUMAN CELL; LIVER MICROSOME; LYMPHOBLASTOID CELL; METABOLIC RATE; MICHAELIS CONSTANT; PHENOTYPE;

STAPHYLOCOCCUS PHAGE 3A;

EID: 0033711957     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/00498250050200113     Document Type: Article

References (36)

1. Diazepam metabolism by human liver microsomes is mediated both by S-mephenytoin hydroxylase and CYP3A isoforms
2. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P4503A and 2C9
3. Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalysed by human liver microsomes
4. A highly sensitive tool for the assay of cytochrome P450 enzyme activity in rat, dog and man. Direct fluorescence monitoring of the deethylation of 7-ethoxy-4-trifluoromethylcoumarin
5. Evaluation of triacetyloleandomycin, α-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450
6. Description of a 96-well plate assay to measure cytochrome P4503A inhibition in human liver microsomes using a selective fluorescent probe
7. In vitro assessment of human cytochrome P450
8. Characterization of the inhibition of P4501A2 by furafylline
9. Human cytochrome P4502B6. Interindividual hepatic expression, substrate specificity, and role in precarcinogen activation
10. Novel high throughput fluorescent cytochrome P450 assays
11. Microtiter plate assays for inhibition of human, drug-metabolizing cytochromes P450
12. High throughput screening for inhibition of cytochrome P450 metabolism
13. Biotransformation of caffeine and theophylline in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms
14. Catalytic role of P4502B6 in the N-demethylation of S-mephenytoin
15. Simultaneous measurement of cytochrome P4501A catalytic activity and total protein concentration with a fluorescent plate reader
16. Preparation and characterisation of microsomal fractions for studies of xenobiotic metabolism
17. Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity: Comparison with two directly hepatotoxic drugs
18. Protein measurement with the Folin phenol reagent
19. Role of a potent inhibitory monoclonal antibody to cytochrome P-450 3A4 in assessment of human drug metabolism
20. Cytochrome P4502C9: An enzyme of major importance in human drug metabolism
21. P450 superfamily : Update on new sequences, gene mapping, accession numbers and nomenclature
22. Cytochrome P450 inhibitors. Evaluation of specificities in the in vitro metabolism of therapeutic agents by human liver microsomes
23. Specificity of substrate and inhibitor probes for cytochrome P450s: Evaluation of in vitro metabolism using cDNA-expressed human P450s and human liver microsomes
24. An overview of current cytochrome P450 technology for assessing the safety and efficacy of new materials
25. Biotransformation of xenobiotics
26. Identification of the human P450 enzymes involved in lansoprazole metabolism
27. Inhibition and induction of human cytochrome P450 (CYP) enzymes
28. Metabolism of zaleplon by human hepatic cytochrome P450 isoforms
29. Integrated cytochrome P450 reaction phenotyping. Attempting to bridge the gap between cDNA-expressed cytochromes P450 and native human liver microsomes
30. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: Studies with liver microsomes of 30 Japanese and 30 Caucasians
31. Caffeine metabolism by human hepatic cytochromes P450: Contributions of 1A2, 2E1 and 3A isoforms
32. The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies
33. Isolation and characterization of human liver cytochrome P450 2C19: Correlation between 2C19 and S-mephenytoin 4'-hydroxylation
34. In vitro methods for assessing human hepatic drug metabolism: Their use in drug development
35. Eight inhibitory monoclonal antibodies define the role of individual P-450s in human liver microsomal diazepam, 7-ethoxycoumarin and imipramine metabolism
36. Cytochrome P450 mediated metabolism of diazepam in human and rat: Involvement of human CYP2C in N-demethylation in the substrate concentration-dependent manner